Concepedia

Andrew Pavelyev

AP

Statistics

Publications

8

Citations

151

H-Index

8

Active since

2017

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

Imperial Consultants

MSD K.K. (Japan)

Chinese University of Hong Kong

Andrew Pavelyev is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in vaccination, preventive medicine, and vaccine effectiveness.

Publications per year

2017–2023

8

Publications

8

Public health impact and cost-effectiveness of a nine-valent gender-neutral HPV vaccination program in France

Laureen Majed, Xavier Bresse, Nadia El Mouaddin et al. · Vaccine · 2020 · 31 citations

, , +14

Clinical and economic impact of school‐based nonavalent human papillomavirus vaccine on women in Singapore: a transmission dynamic mathematical model analysis

S K Tay, T.Y. Hsu, Andrew Pavelyev et al. · BJOG An International Journal of Obstetrics & Gynaecology · 2017 · 23 citations

, , +17

Health impact and cost-effectiveness of implementing gender-neutral vaccination with the 9-valent HPV vaccine in Hong Kong

Tak Hong Cheung, Sally Shuk Yee Cheng, Danny Hsu et al. · Human Vaccines & Immunotherapeutics · 2023 · 21 citations · Full text

, , +17

The epidemiologic and economic impact of a quadrivalent human papillomavirus vaccine in Thailand

Wichai Termrungruanglert, Nipon Khemapech, Apichai Vasuratna et al. · PLoS ONE · 2021 · 19 citations · Full text

, , +17

The impact and cost-effectiveness of 9-valent human papillomavirus vaccine in adolescent females in Hong Kong

Tak Hong Cheung, Sally Shuk Yee Cheng, Danny Hsu et al. · Cost Effectiveness and Resource Allocation · 2021 · 15 citations · Full text

, , +17

1–5 of 8